TU-D-207B-02: Delta-Radiomics: The Prognostic Value of Therapy-Induced Changes in Radiomics Features for Stage III Non-Small Cell Lung Cancer Patients

2016 ◽  
Vol 43 (6Part34) ◽  
pp. 3750-3750 ◽  
Author(s):  
X Fave ◽  
L Zhang ◽  
J Yang ◽  
D Mackin ◽  
F Stingo ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cancer Patients ◽  
Cell Lung Cancer ◽  
Prognostic Value ◽  
Small Cell ◽  
Stage Iii ◽  
Small Cell Lung ◽  
Lung Cancer Patients ◽  
Induced Changes

Prognostic value of survivin expression in stage III non-small cell lung cancer patients treated with platinum-based therapy

2015 ◽  
Vol 24 (4) ◽  
pp. 329-334 ◽  
Author(s):  
Hyun Jin Cho ◽  
Hyeong Ryul Kim ◽  
Young Soo Park ◽  
Yong-Hee Kim ◽  
Dong Kwan Kim ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cancer Patients ◽  
Cell Lung Cancer ◽  
Prognostic Value ◽  
Survivin Expression ◽  
Small Cell ◽  
Stage Iii ◽  
Small Cell Lung ◽  
Lung Cancer Patients

Ineligibility for the PACIFIC trial in unresectable stage III non-small cell lung cancer patients

2019 ◽  
Vol 84 (2) ◽  
pp. 275-280 ◽  
Author(s):  
Kazutaka Hosoya ◽  
Daichi Fujimoto ◽  
Hayato Kawachi ◽  
Yuki Sato ◽  
Mariko Kogo ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cancer Patients ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Stage Iii ◽  
Small Cell Lung ◽  
Lung Cancer Patients ◽  
Unresectable Stage ◽  
The Pacific
Sign in / Sign up

Export Citation Format

Share Document